Derek D. Satre
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Derek D. Satre has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
Michael J. Silverberg
Kaiser Permanente Northern California, Division of Research, Pleasanton, CA 94588, United States of America
8 shared publicationsKelly C. Young-Wolff
Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, California
7 shared publicationsStacy A. Sterling
Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences University of California San Francisco CA USA
6 shared publicationsPaul Volberding
AIDS Research Institute, University of California, San Francisco, USA
5 shared publications- Stacy A. Sterling
Division of Research, Kaiser Permanente Northern California, Oakland, USA
5 shared publications Amy S. Leibowitz
Kaiser Permanente Northern California, Division of Research, Pleasanton, CA 94588, United States of America
4 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 50 (9) , e70398
Syndemic Classes of Unhealthy Alcohol Use Reveal Inequities in Alcohol‐Related Consequences and HIV Care Outcomes
Background: Unhealthy alcohol use among people with HIV (PWH) often co‐occurs with medical and mental health conditions and may negatively impact patient care. We examined syndemic classes of unhealthy alcohol use, substance use and comorbidities and their links to sociodemographic factors, alcohol treatment access, and HIV care outcomes. Methods: Participants were 4574 adult PWH in Kaiser Permanente Northern California who reported alcohol use on routine primary care screening between 2013 and 2020 (index date). Latent class analysis identified subgroups based on alcohol use level and co‐occurring conditions in the prior year, including smoking, alcohol and other substance use disorders, mental health diagnoses, chronic medical conditions, obesity, insufficient physical activity, and sexually transmitted infections. Age, race/ethnicity, sex, and HIV risk status were examined as predictors of class membership using latent class analysis (LCA) with covariates. HIV outcomes (viral suppression < 200 copies/mL, retention in care) and alcohol treatment in the year post‐index (psychotherapy, medication) were compared across classes using Bolck, Croon, and Hagenaars (BCH) three‐step procedure. Results: Four classes were identified: Heavy Use/Complex Behavioral Multimorbidity, Moderate Use/High Cardiometabolic Burden, Low Use/High Medical Morbidity, and Moderate Use/Low Morbidity. Black and women PWH were more likely to belong to the Moderate Use/High Cardiometabolic Burden class, while men who have sex with men were less likely to belong to the Heavy Use/Complex Behavioral Multimorbidity class. Classes differed in care outcomes: the Low Use/High Medical Morbidity class had the highest HIV care retention and viral suppression; the Heavy Use/Complex Behavioral Multimorbidity class had the highest alcohol treatment receipt; and the Moderate Use/High Cardiometabolic Burden class had the lowest psychotherapy rates. Conclusions: Syndemic patterns of alcohol use and multimorbidity among PWH were associated with disparities in HIV outcomes and alcohol treatment. Findings highlight missed opportunities for integrated alcohol and cardiometabolic care and support targeted interventions to improve engagement.
- 17 September 2026
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 50 (9) , e70398
Open AccessSyndemic Classes of Unhealthy Alcohol Use Reveal Inequities in Alcohol‐Related Consequences and HIV Care Outcomes
Background: Unhealthy alcohol use among people with HIV (PWH) often co‐occurs with medical and mental health conditions and may negatively impact patient care. We examined syndemic classes of unhealthy alcohol use, substance use and comorbidities and their links to sociodemographic factors, alcohol treatment access, and HIV care outcomes. Methods: Participants were 4574 adult PWH in Kaiser Permanente Northern California who reported alcohol use on routine primary care screening between 2013 and 2020 (index date). Latent class analysis identified subgroups based on alcohol use level and co‐occurring conditions in the prior year, including smoking, alcohol and other substance use disorders, mental health diagnoses, chronic medical conditions, obesity, insufficient physical activity, and sexually transmitted infections. Age, race/ethnicity, sex, and HIV risk status were examined as predictors of class membership using latent class analysis (LCA) with covariates. HIV outcomes (viral suppression < 200 copies/mL, retention in care) and alcohol treatment in the year post‐index (psychotherapy, medication) were compared across classes using Bolck, Croon, and Hagenaars (BCH) three‐step procedure. Results: Four classes were identified: Heavy Use/Complex Behavioral Multimorbidity, Moderate Use/High Cardiometabolic Burden, Low Use/High Medical Morbidity, and Moderate Use/Low Morbidity. Black and women PWH were more likely to belong to the Moderate Use/High Cardiometabolic Burden class, while men who have sex with men were less likely to belong to the Heavy Use/Complex Behavioral Multimorbidity class. Classes differed in care outcomes: the Low Use/High Medical Morbidity class had the highest HIV care retention and viral suppression; the Heavy Use/Complex Behavioral Multimorbidity class had the highest alcohol treatment receipt; and the Moderate Use/High Cardiometabolic Burden class had the lowest psychotherapy rates. Conclusions: Syndemic patterns of alcohol use and multimorbidity among PWH were associated with disparities in HIV outcomes and alcohol treatment. Findings highlight missed opportunities for integrated alcohol and cardiometabolic care and support targeted interventions to improve engagement.
- Open Access
- 16 September 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Between Craving and Connection: A Mixed Methods Provider Perspectives on Generative AI Chatbots for Alcohol Treatment (Preprint)
BACKGROUND Generative artificial intelligence (AI) chatbots are increasingly proposed as scalable tools to support behavioral health care, including alcohol use reduction interventions. However, little is known about how providers perceive their clinical value, risks, and implementation needs, particularly for patients with co-occurring mental health concerns. OBJECTIVE This study aimed to examine behavioral health providers’ perspectives on the potential roles, value, and implementation considerations of AI chatbots designed to support alcohol use reduction, particularly for patients with co-occurring anxiety or depression. METHODS We conducted a mixed-methods study with 22 behavioral health providers who had experience treating alcohol and mental health problems across primary care, psychiatry, and addiction medicine within a large integrated U.S. health system. Providers completed semi-structured interviews exploring perceived roles, engagement factors, safety considerations, and equity implications of AI chatbots for alcohol care, followed by a survey assessing attitudes toward AI using an adapted technology acceptance scale. Interviews were thematically analyzed, and quantitative data were summarized descriptively. RESULTS Quantitative findings indicated moderately positive overall attitudes toward AI chatbots in the context of alcohol and mental health care, with strong endorsement of their potential for psychoeducation, increased access to care, and motivation enhancement, alongside concerns regarding trustworthiness and the need for strict clinical oversight. Qualitative analysis identified five themes: cautious optimism; targeting cravings, high-risk moments, and relapse prevention ; prerequisites for engagement (personalization and emotional responsiveness); safety and escalation needs; and extending the alcohol care continuum to patients not ready for treatment. CONCLUSIONS Providers viewed AI chatbots as a promising adjunctive alcohol treatment, particularly for patients with co-occurring mental health needs and those experiencing stigma, ambivalence, or limited care access, with notable caveats. Successful integration requires human-centered design, robust safety guardrails, and alignment with clinical workflows. CLINICALTRIAL N/A
- 16 September 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessBetween Craving and Connection: A Mixed Methods Provider Perspectives on Generative AI Chatbots for Alcohol Treatment (Preprint)
BACKGROUND Generative artificial intelligence (AI) chatbots are increasingly proposed as scalable tools to support behavioral health care, including alcohol use reduction interventions. However, little is known about how providers perceive their clinical value, risks, and implementation needs, particularly for patients with co-occurring mental health concerns. OBJECTIVE This study aimed to examine behavioral health providers’ perspectives on the potential roles, value, and implementation considerations of AI chatbots designed to support alcohol use reduction, particularly for patients with co-occurring anxiety or depression. METHODS We conducted a mixed-methods study with 22 behavioral health providers who had experience treating alcohol and mental health problems across primary care, psychiatry, and addiction medicine within a large integrated U.S. health system. Providers completed semi-structured interviews exploring perceived roles, engagement factors, safety considerations, and equity implications of AI chatbots for alcohol care, followed by a survey assessing attitudes toward AI using an adapted technology acceptance scale. Interviews were thematically analyzed, and quantitative data were summarized descriptively. RESULTS Quantitative findings indicated moderately positive overall attitudes toward AI chatbots in the context of alcohol and mental health care, with strong endorsement of their potential for psychoeducation, increased access to care, and motivation enhancement, alongside concerns regarding trustworthiness and the need for strict clinical oversight. Qualitative analysis identified five themes: cautious optimism; targeting cravings, high-risk moments, and relapse prevention ; prerequisites for engagement (personalization and emotional responsiveness); safety and escalation needs; and extending the alcohol care continuum to patients not ready for treatment. CONCLUSIONS Providers viewed AI chatbots as a promising adjunctive alcohol treatment, particularly for patients with co-occurring mental health needs and those experiencing stigma, ambivalence, or limited care access, with notable caveats. Successful integration requires human-centered design, robust safety guardrails, and alignment with clinical workflows. CLINICALTRIAL N/A
- 24 June 2026
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (6) , 1846-1859
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease
Background and Aims: Unhealthy alcohol use is prevalent in chronic liver disease (CLD). This randomized controlled trial evaluated the efficacy of telehealth stepped alcohol treatment (SAT) in 3 healthcare systems. Approach and Results: Participants (N=157) with CLD and unhealthy alcohol use (>7 drinks/week or ≥4/day for women; >14/week or ≥5/day for men; or heavy episodic drinking, using timeline followback), were enrolled at a safety-net and 2 Veterans Affairs hepatology clinics from March 1, 2022, to February 28, 2024. Participants were randomized to SAT (N=81; Step 1: three motivational interviewing sessions; Step 2: addiction medicine referral if no drinking reduction at month 3) or usual care (UC; N=76) and were evaluated at months 3 and 6. Alcohol use reduction was analyzed using bivariate tests and multivariable modeling. Baseline characteristics were: median age 61, 86% male, 48% with cirrhosis (37% decompensation), and 78% with alcohol use disorder. Compared with UC, SAT had no difference in percentage of alcohol use below moderate level (primary outcome) but had a greater reduction in drinks/week from baseline to month 3 (estimate −0.66, p =0.03) and month 6 (estimate −0.67, p =0.03) (secondary outcome). The 6-month effect of SAT (vs. UC) on alcohol use reduction remained significant ( p =0.02), controlling for covariates. At month 6, 30-day abstinence rates were 29% for SAT and 18% for UC ( p =0.14). Baseline motivation to reduce alcohol use was positively associated with treatment response. Conclusions: SAT was not superior on the primary outcome, yet reduced alcohol use more than UC at 6 months in this difficult-to-engage population and may be valuable in hepatology.
- 24 June 2026
- Published by Wolters Kluwer Health in Hepatology
- Vol. 84 (6) , 1846-1859
A randomized controlled trial of stepped treatment to reduce unhealthy alcohol use in patients with chronic liver disease
Background and Aims: Unhealthy alcohol use is prevalent in chronic liver disease (CLD). This randomized controlled trial evaluated the efficacy of telehealth stepped alcohol treatment (SAT) in 3 healthcare systems. Approach and Results: Participants (N=157) with CLD and unhealthy alcohol use (>7 drinks/week or ≥4/day for women; >14/week or ≥5/day for men; or heavy episodic drinking, using timeline followback), were enrolled at a safety-net and 2 Veterans Affairs hepatology clinics from March 1, 2022, to February 28, 2024. Participants were randomized to SAT (N=81; Step 1: three motivational interviewing sessions; Step 2: addiction medicine referral if no drinking reduction at month 3) or usual care (UC; N=76) and were evaluated at months 3 and 6. Alcohol use reduction was analyzed using bivariate tests and multivariable modeling. Baseline characteristics were: median age 61, 86% male, 48% with cirrhosis (37% decompensation), and 78% with alcohol use disorder. Compared with UC, SAT had no difference in percentage of alcohol use below moderate level (primary outcome) but had a greater reduction in drinks/week from baseline to month 3 (estimate −0.66, p =0.03) and month 6 (estimate −0.67, p =0.03) (secondary outcome). The 6-month effect of SAT (vs. UC) on alcohol use reduction remained significant ( p =0.02), controlling for covariates. At month 6, 30-day abstinence rates were 29% for SAT and 18% for UC ( p =0.14). Baseline motivation to reduce alcohol use was positively associated with treatment response. Conclusions: SAT was not superior on the primary outcome, yet reduced alcohol use more than UC at 6 months in this difficult-to-engage population and may be valuable in hepatology.
- Open Access
- 30 May 2026
- Published by Springer Nature in Cognitive Therapy and Research
- Vol. 50 (5) , 948-959
Threat Sensitivity, Stress, and Alcohol Use in Probable PTSD: Findings from a Mobile Attention Bias Modification Trial
Purpose: Posttraumatic stress disorder (PTSD) is characterized by heightened threat sensitivity, including attentional bias to threat, and associated with increased alcohol consumption. Given that alcohol consumption may be driven by or worsen PTSD symptoms, it is critical to consider how threat sensitivity relates to drinking in individuals with probable PTSD. Methods: In this study, 687 adults with probable PTSD (PTSD Checklist for DSM-5 symptoms ≥ 33; M age =30.01; 80% female) completed a 15-day app-based attention bias modification (ABM) protocol to reduce threat-related biases. Participants were randomized into personalized ABM, non-personalized ABM, or placebo training (days 2–7, 9–14), and completed dot-probe detection assessments on days 1, 8, and 15. Participants reported alcoholic drinks consumed in the past 24 h every training day. We examined associations of ABM condition, threat sensitivity (self-reported, avoidance and vigilance reaction time biases), stress (past, anticipated), and PTSD symptoms with alcohol consumption (drink count, heavy drinking) using mixed models. Results: Personalized ABM was not significantly associated with reduced drink count, relative to placebo (rate ratio [RR] = 0.72, 95% CI 0.51, 1.01). Higher self-reported threat sensitivity was associated with lower next-day drink count ( RR = 0.93, 95% CI 0.87, 0.99; marginal after multiple corrections), while there was a non-significant effect between avoidance bias and lower next-day drink count ( RR = 0.88, 95% CI 0.76, 1.02). Higher past and anticipated stress were associated with lower next-day drink count ( RR = 0.92, 95% CI 0.87, 0.96) and heavy drinking (odds ratio [OR] = 0.91, 95% CI 0.82, 1.00), respectively. Conclusions: Our findings link threat sensitivity and stress with subsequent lower alcohol consumption, necessitating further research on the intersection of these factors with alcohol use in populations with probable PTSD.
- 30 May 2026
- Published by Springer Nature in Cognitive Therapy and Research
- Vol. 50 (5) , 948-959
Open AccessThreat Sensitivity, Stress, and Alcohol Use in Probable PTSD: Findings from a Mobile Attention Bias Modification Trial
Purpose: Posttraumatic stress disorder (PTSD) is characterized by heightened threat sensitivity, including attentional bias to threat, and associated with increased alcohol consumption. Given that alcohol consumption may be driven by or worsen PTSD symptoms, it is critical to consider how threat sensitivity relates to drinking in individuals with probable PTSD. Methods: In this study, 687 adults with probable PTSD (PTSD Checklist for DSM-5 symptoms ≥ 33; M age =30.01; 80% female) completed a 15-day app-based attention bias modification (ABM) protocol to reduce threat-related biases. Participants were randomized into personalized ABM, non-personalized ABM, or placebo training (days 2–7, 9–14), and completed dot-probe detection assessments on days 1, 8, and 15. Participants reported alcoholic drinks consumed in the past 24 h every training day. We examined associations of ABM condition, threat sensitivity (self-reported, avoidance and vigilance reaction time biases), stress (past, anticipated), and PTSD symptoms with alcohol consumption (drink count, heavy drinking) using mixed models. Results: Personalized ABM was not significantly associated with reduced drink count, relative to placebo (rate ratio [RR] = 0.72, 95% CI 0.51, 1.01). Higher self-reported threat sensitivity was associated with lower next-day drink count ( RR = 0.93, 95% CI 0.87, 0.99; marginal after multiple corrections), while there was a non-significant effect between avoidance bias and lower next-day drink count ( RR = 0.88, 95% CI 0.76, 1.02). Higher past and anticipated stress were associated with lower next-day drink count ( RR = 0.92, 95% CI 0.87, 0.96) and heavy drinking (odds ratio [OR] = 0.91, 95% CI 0.82, 1.00), respectively. Conclusions: Our findings link threat sensitivity and stress with subsequent lower alcohol consumption, necessitating further research on the intersection of these factors with alcohol use in populations with probable PTSD.
Are cannabis policy changes associated with alcohol use patterns? Evidence for age‐group differences based on primary care screening data
Background and Aims: In California, USA, adult cannabis legalization (ACL) was passed in 2016, with implementation of legal sales commencing in 2018. This study examined whether these policy changes were associated with changes in alcohol use patterns and explored age‐group differences.Design: We examined monthly rates of positive alcohol screens in primary care patients in California from 2015 to 2019. Using an interrupted time series design and autoregressive integrated moving average (ARIMA) models, changes were evaluated in the overall sample and stratified by age groups (21–34, 35–64 and 65+) across two key intervention points for ACL: 9 November 2016 (ACL passage) and 1 January 2018 (ACL implementation). Time‐varying confounders of seasonality and autocorrelation were controlled for.Setting: California, United States; Kaiser Permanente Northern California Healthcare System.Participants: Across the study period, n = 8 028 627 screenings were completed for n= 3 525 493 unique patients aged 21+ .Measurements: Aggregated monthly rates of patients exceeding daily limits, weekly limits, exceeding both daily and weekly limits and frequent heavy episodic drinking (HED), based on current US guidelines set by the National Institute on Alcohol Abuse and Alcoholism.Findings: Statistically significant, gradual declines in rates of both exceeding weekly alcohol limits [estimate (95% confidence interval [CI]) of slope change = −0.013(−0.019 to −0.008), P < 0.001] and frequent HED followed ACL passage [estimate (95% CI) of slope change = −0.015(−0.024 to −0.005), P = 0.003]. ACL implementation was generally not associated with further changes, suggesting changes after ACL passage were sustained over time. Age‐group patterns varied: young adults (21–34) demonstrated an immediate increase, followed by a statistically significant gradual decline in rates of HED post‐ACL passage [estimate (95% CI) of slope change = −0.096(−0.160, −0.033), P = 0.003], as well as an immediate decrease post ACL implementation; adults 35–49 showed consistent declines in step and slope in rates of frequent HED post ACL passage; adults 50–64 showed an immediate increase in rates of exceeding weekly limits [estimate (95% CI) of step change = 0.167(0.036–0.297), P = 0.012], with gradual declines in the other drinking limits; adults 65 + had small, gradual decreases. In addition, exploratory analyses in 18–20‐year‐olds showed gradual increases in rates of frequent HED post ACL passage, but the P value was not significant after Bonferroni correction.Conclusions: Cannabis policy changes in California, USA, appear to be linked to age‐specific changes in alcohol use, with moderate reductions, particularly among middle‐aged adults. Findings were associative in nature and causality could not be determined.
Are cannabis policy changes associated with alcohol use patterns? Evidence for age‐group differences based on primary care screening data
Background and Aims: In California, USA, adult cannabis legalization (ACL) was passed in 2016, with implementation of legal sales commencing in 2018. This study examined whether these policy changes were associated with changes in alcohol use patterns and explored age‐group differences.Design: We examined monthly rates of positive alcohol screens in primary care patients in California from 2015 to 2019. Using an interrupted time series design and autoregressive integrated moving average (ARIMA) models, changes were evaluated in the overall sample and stratified by age groups (21–34, 35–64 and 65+) across two key intervention points for ACL: 9 November 2016 (ACL passage) and 1 January 2018 (ACL implementation). Time‐varying confounders of seasonality and autocorrelation were controlled for.Setting: California, United States; Kaiser Permanente Northern California Healthcare System.Participants: Across the study period, n = 8 028 627 screenings were completed for n= 3 525 493 unique patients aged 21+ .Measurements: Aggregated monthly rates of patients exceeding daily limits, weekly limits, exceeding both daily and weekly limits and frequent heavy episodic drinking (HED), based on current US guidelines set by the National Institute on Alcohol Abuse and Alcoholism.Findings: Statistically significant, gradual declines in rates of both exceeding weekly alcohol limits [estimate (95% confidence interval [CI]) of slope change = −0.013(−0.019 to −0.008), P < 0.001] and frequent HED followed ACL passage [estimate (95% CI) of slope change = −0.015(−0.024 to −0.005), P = 0.003]. ACL implementation was generally not associated with further changes, suggesting changes after ACL passage were sustained over time. Age‐group patterns varied: young adults (21–34) demonstrated an immediate increase, followed by a statistically significant gradual decline in rates of HED post‐ACL passage [estimate (95% CI) of slope change = −0.096(−0.160, −0.033), P = 0.003], as well as an immediate decrease post ACL implementation; adults 35–49 showed consistent declines in step and slope in rates of frequent HED post ACL passage; adults 50–64 showed an immediate increase in rates of exceeding weekly limits [estimate (95% CI) of step change = 0.167(0.036–0.297), P = 0.012], with gradual declines in the other drinking limits; adults 65 + had small, gradual decreases. In addition, exploratory analyses in 18–20‐year‐olds showed gradual increases in rates of frequent HED post ACL passage, but the P value was not significant after Bonferroni correction.Conclusions: Cannabis policy changes in California, USA, appear to be linked to age‐specific changes in alcohol use, with moderate reductions, particularly among middle‐aged adults. Findings were associative in nature and causality could not be determined.
- 1 January 2025
- Published by National Institute on Alcohol Abuse and Alcoholism in Alcohol Research: Current Reviews
- Vol. 45 (1)
Alcohol Use and Its Associations With Frailty, Fractures, and Falls Among Older Adults With HIV
More than half of people with HIV (PWH) in the United States are now over age 50. Although alcohol consumption declines with age among PWH, as it does in the general population, alcohol misuse and alcohol use disorder (AUD) pose substantial health risks. Aging leads to increased sensitivity to alcohol due to slower metabolism, central nervous system changes, less lean body mass, greater prevalence of co-occurring medical conditions, and polypharmacy (simultaneous use of multiple medicines). These vulnerabilities heighten the adverse effects of alcohol use among older PWH compared with both younger PWH and people without HIV of all ages. This review examines associations between alcohol use and three interrelated health outcomes of growing research interest—frailty, fractures, and falls—each of which has substantial negative impacts on longevity and quality of life among PWH and may be influenced by alcohol use. Search terms included alcohol, drinking, binge drinking, heavy drinking, AUD, alcohol abuse, alcohol dependence, problematic alcohol use, mild/moderate alcohol use, high-intensity drinking, risky drinking, alcoholism, frailty, falls, fractures, HIV, PWH, PLWH, ART, and AIDS. All studies included PWH age 50 and over. In June 2024, authors identified original studies published in English between June 1, 2014, and June 1, 2024, by searching PubMed, Web of Science, and ScienceDirect and reviewing reference lists of reviews and meta-analyses identified in the search. Searches yielded a total of 512 articles; 114 duplicates were removed. Two independent reviewers screened the abstracts of the remaining 398 articles, of which 326 articles were excluded based on having inappropriate sampling, exposures, or outcome measures. Seventy-two articles underwent full-text review; of these, 14 articles met inclusion criteria and 58 articles were excluded. Reasons for exclusion were wrong outcomes (n = 12), no drinking or alcohol quantification (n = 15), wrong population (n = 8), outside of timeframe (n = 3), not in English (n = 2), wrong frailty measure (n = 9), and review/meta-analysis (n = 9). Results across the 14 studies indicated that, among older PWH, greater alcohol use was linked to higher risk of frailty, fractures, and falls. However, evidence was limited, with most literature based on observational studies. Important future potential research directions include longitudinal assessments of alcohol–frailty relationships among PWH age 50 and over; evaluating the role of alcohol use in the development and progression of frailty accounting for mid- and later-life comorbidity and resultant polypharmacy; and examining moderators of the alcohol–frailty relationship. Future research examining interventions to reduce risk of frailty, fractures, and falls among aging PWH also would be beneficial.
- 1 January 2025
- Published by National Institute on Alcohol Abuse and Alcoholism in Alcohol Research: Current Reviews
- Vol. 45 (1)
Alcohol Use and Its Associations With Frailty, Fractures, and Falls Among Older Adults With HIV
More than half of people with HIV (PWH) in the United States are now over age 50. Although alcohol consumption declines with age among PWH, as it does in the general population, alcohol misuse and alcohol use disorder (AUD) pose substantial health risks. Aging leads to increased sensitivity to alcohol due to slower metabolism, central nervous system changes, less lean body mass, greater prevalence of co-occurring medical conditions, and polypharmacy (simultaneous use of multiple medicines). These vulnerabilities heighten the adverse effects of alcohol use among older PWH compared with both younger PWH and people without HIV of all ages. This review examines associations between alcohol use and three interrelated health outcomes of growing research interest—frailty, fractures, and falls—each of which has substantial negative impacts on longevity and quality of life among PWH and may be influenced by alcohol use. Search terms included alcohol, drinking, binge drinking, heavy drinking, AUD, alcohol abuse, alcohol dependence, problematic alcohol use, mild/moderate alcohol use, high-intensity drinking, risky drinking, alcoholism, frailty, falls, fractures, HIV, PWH, PLWH, ART, and AIDS. All studies included PWH age 50 and over. In June 2024, authors identified original studies published in English between June 1, 2014, and June 1, 2024, by searching PubMed, Web of Science, and ScienceDirect and reviewing reference lists of reviews and meta-analyses identified in the search. Searches yielded a total of 512 articles; 114 duplicates were removed. Two independent reviewers screened the abstracts of the remaining 398 articles, of which 326 articles were excluded based on having inappropriate sampling, exposures, or outcome measures. Seventy-two articles underwent full-text review; of these, 14 articles met inclusion criteria and 58 articles were excluded. Reasons for exclusion were wrong outcomes (n = 12), no drinking or alcohol quantification (n = 15), wrong population (n = 8), outside of timeframe (n = 3), not in English (n = 2), wrong frailty measure (n = 9), and review/meta-analysis (n = 9). Results across the 14 studies indicated that, among older PWH, greater alcohol use was linked to higher risk of frailty, fractures, and falls. However, evidence was limited, with most literature based on observational studies. Important future potential research directions include longitudinal assessments of alcohol–frailty relationships among PWH age 50 and over; evaluating the role of alcohol use in the development and progression of frailty accounting for mid- and later-life comorbidity and resultant polypharmacy; and examining moderators of the alcohol–frailty relationship. Future research examining interventions to reduce risk of frailty, fractures, and falls among aging PWH also would be beneficial.
- 11 November 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (3) , 481-490
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
Background and Aims: Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce drinking.Methods: Participants (N = 121) with unhealthy alcohol use (i.e., over NIH guidelines) receiving care in hepatology clinics from a safety‐net hospital (SN, N = 54) and two Veterans Affairs Healthcare Systems (VA, N = 67) were enrolled in an alcohol intervention trial from March 2022 through October 2023. Baseline assessments included Generalised Anxiety Disorder (GAD‐7), Patient Health Questionnaire (PHQ‐8), Alcohol Use Disorders Identification Test (AUDIT), COVID‐19 stress; and measures of importance and confidence to decrease alcohol use (readiness rulers, scales of 1–10). Liver disease aetiology and severity were extracted from electronic health records. We performed multivariable linear regression models with forward selection to assess pre‐specified variables' associations with importance and confidence.Results: The sample was 84% male, 40% Latino, 31% White, 18% Black and 11% other races; median age was 61 years. Median (Q1–Q3) AUDIT score was 16 (12–24), importance was 9 (6–10) and confidence was 8 (5–9). On multivariable analysis, VA site (vs. SN) participants had a 0.97‐point lower importance score (p = 0.02); higher symptoms of depression (PHQ‐8 score ≥ 10 vs. < 10) and AUDIT scores (for each point increase) were associated with higher importance score (estimates 1.2 and 0.08, p < 0.05, respectively). Liver disease aetiology and severity were not significantly associated with outcomes.Conclusions: Depression, alcohol problem severity and treatment site may influence motivation to reduce alcohol use and could inform future hepatology‐based interventions.
- 11 November 2024
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (3) , 481-490
Factors Associated With Motivation to Reduce Alcohol Use Among Patients With Chronic Liver Disease
Background and Aims: Alcohol use is prevalent among hepatology clinic patients with chronic liver disease (CLD). We explored factors associated with the importance and confidence dimensions of motivation to reduce drinking.Methods: Participants (N = 121) with unhealthy alcohol use (i.e., over NIH guidelines) receiving care in hepatology clinics from a safety‐net hospital (SN, N = 54) and two Veterans Affairs Healthcare Systems (VA, N = 67) were enrolled in an alcohol intervention trial from March 2022 through October 2023. Baseline assessments included Generalised Anxiety Disorder (GAD‐7), Patient Health Questionnaire (PHQ‐8), Alcohol Use Disorders Identification Test (AUDIT), COVID‐19 stress; and measures of importance and confidence to decrease alcohol use (readiness rulers, scales of 1–10). Liver disease aetiology and severity were extracted from electronic health records. We performed multivariable linear regression models with forward selection to assess pre‐specified variables' associations with importance and confidence.Results: The sample was 84% male, 40% Latino, 31% White, 18% Black and 11% other races; median age was 61 years. Median (Q1–Q3) AUDIT score was 16 (12–24), importance was 9 (6–10) and confidence was 8 (5–9). On multivariable analysis, VA site (vs. SN) participants had a 0.97‐point lower importance score (p = 0.02); higher symptoms of depression (PHQ‐8 score ≥ 10 vs. < 10) and AUDIT scores (for each point increase) were associated with higher importance score (estimates 1.2 and 0.08, p < 0.05, respectively). Liver disease aetiology and severity were not significantly associated with outcomes.Conclusions: Depression, alcohol problem severity and treatment site may influence motivation to reduce alcohol use and could inform future hepatology‐based interventions.
- 7 May 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 358, 369-376
Factors associated with suicidal ideation among people with HIV engaged in care
- 7 May 2024
- Published by Elsevier in Journal of Affective Disorders
- Vol. 358, 369-376
Factors associated with suicidal ideation among people with HIV engaged in care
- Open Access
- 29 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (13) , e37581
Self-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study
Persons with HIV (PWH) experience high levels of pain. We examined the relationship of pain severity with use of cannabis and prescription opioids among PWH. This cross-sectional study evaluated associations between self-reported pain (moderate/severe vs mild/none) and cannabis and prescription opioid use in a primary care sample of PWH enrolled in an alcohol use treatment study at Kaiser Permanente, San Francisco. Prevalence ratios (PR) for moderate/severe pain associated with cannabis, opioid use, or both in the prior 30 days were obtained from Poisson regression models. Adjusted models included race/ethnicity, education, employment, HIV ribonucleic acid levels, depression, and anxiety. Overall, 614 PWH completed baseline questionnaires from May 2013 to May 2015, among whom 182/614 (29.6%) reported moderate/severe pain. The prevalence of moderate/severe pain varied by substances: 19.1% moderate/severe pain among study participants who reported neither cannabis or opioids, 30.2% for cannabis alone, 41.2% for opioids alone, and 60.9% for those reporting both substances. In adjusted models, compared with PWH who reported neither substance (reference), prevalence of moderate/severe pain was higher for those using cannabis alone (PR 1.54; 95% CI 1.13–2.09), opioids alone (PR 1.96; 95% CI 1.31–2.94), and those reporting both (PR 2.66; 95% CI 1.91–3.70). PWH who reported opioid and/or cannabis use were more likely to report moderate/severe pain compared with PWH who did not report use of these substances. To improve patient care, it is vital to assess patients’ approaches to pain management including substance use and target appropriate interventions to reduce pain in PWH.
- 29 March 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (13) , e37581
Open AccessSelf-reported pain severity and use of cannabis and opioids in persons with HIV in an urban primary care setting in Northern California: A cross-sectional study
Persons with HIV (PWH) experience high levels of pain. We examined the relationship of pain severity with use of cannabis and prescription opioids among PWH. This cross-sectional study evaluated associations between self-reported pain (moderate/severe vs mild/none) and cannabis and prescription opioid use in a primary care sample of PWH enrolled in an alcohol use treatment study at Kaiser Permanente, San Francisco. Prevalence ratios (PR) for moderate/severe pain associated with cannabis, opioid use, or both in the prior 30 days were obtained from Poisson regression models. Adjusted models included race/ethnicity, education, employment, HIV ribonucleic acid levels, depression, and anxiety. Overall, 614 PWH completed baseline questionnaires from May 2013 to May 2015, among whom 182/614 (29.6%) reported moderate/severe pain. The prevalence of moderate/severe pain varied by substances: 19.1% moderate/severe pain among study participants who reported neither cannabis or opioids, 30.2% for cannabis alone, 41.2% for opioids alone, and 60.9% for those reporting both substances. In adjusted models, compared with PWH who reported neither substance (reference), prevalence of moderate/severe pain was higher for those using cannabis alone (PR 1.54; 95% CI 1.13–2.09), opioids alone (PR 1.96; 95% CI 1.31–2.94), and those reporting both (PR 2.66; 95% CI 1.91–3.70). PWH who reported opioid and/or cannabis use were more likely to report moderate/severe pain compared with PWH who did not report use of these substances. To improve patient care, it is vital to assess patients’ approaches to pain management including substance use and target appropriate interventions to reduce pain in PWH.
- Open Access
- 1 February 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (2)
Problematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis
Background: Management of cirrhosis is challenging and has been complicated by the COVID-19 pandemic due to decreased access to care, increased psychological distress, and alcohol misuse. Recently, The National Institute on Alcohol Abuse and Alcoholism has broadened the definition of recovery from alcohol use disorder to include quality of life (QoL) as an indicator of recovery. This study examined the associations of alcohol-associated cirrhosis etiology and problematic drinking with liver disease QoL (LDQoL). Methods: Patients with cirrhosis (N=329) were recruited from 3 sites (63% from 2 Veterans Affairs Health Care Systems and 37% from 1 safety net hospital) serving populations that are economically or socially marginalized. Cirrhosis etiology was ascertained by chart review of medical records. Problematic drinking was defined by ≥8 on the Alcohol Use Disorders Identification Test. Multivariable general linear modeling adjusting for age, sex, race/ethnicity, site, pandemic-related stress, and history of anxiety/depressive disorder were conducted. Sensitivity analyses further adjusted for indicators of liver disease severity. Results: Participants were on average 64.6 years old, 17% female, 58% non-White, 44% with alcohol-associated cirrhosis, and 17% with problematic drinking. Problematic drinking was significantly associated with worse LDQoL scores in the overall scale and in the memory/concentration and health distress subscales. These associations remained significant after adjusting for indicators of liver disease severity, including Model for End-Stage Liver Disease-Sodium score and decompensated cirrhosis status. Conclusions: Among patients with cirrhosis, problematic drinking was associated with worse LDQoL, especially in the domains of memory/concentration and health distress. Assessment and awareness of cognitive deficits and negative emotionality within the context of cirrhosis and problematic drinking may help clinicians provide better integrated care for this population. Export
- 1 February 2024
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 8 (2)
Open AccessProblematic alcohol use and its impact on liver disease quality of life in a multicenter study of patients with cirrhosis
Background: Management of cirrhosis is challenging and has been complicated by the COVID-19 pandemic due to decreased access to care, increased psychological distress, and alcohol misuse. Recently, The National Institute on Alcohol Abuse and Alcoholism has broadened the definition of recovery from alcohol use disorder to include quality of life (QoL) as an indicator of recovery. This study examined the associations of alcohol-associated cirrhosis etiology and problematic drinking with liver disease QoL (LDQoL). Methods: Patients with cirrhosis (N=329) were recruited from 3 sites (63% from 2 Veterans Affairs Health Care Systems and 37% from 1 safety net hospital) serving populations that are economically or socially marginalized. Cirrhosis etiology was ascertained by chart review of medical records. Problematic drinking was defined by ≥8 on the Alcohol Use Disorders Identification Test. Multivariable general linear modeling adjusting for age, sex, race/ethnicity, site, pandemic-related stress, and history of anxiety/depressive disorder were conducted. Sensitivity analyses further adjusted for indicators of liver disease severity. Results: Participants were on average 64.6 years old, 17% female, 58% non-White, 44% with alcohol-associated cirrhosis, and 17% with problematic drinking. Problematic drinking was significantly associated with worse LDQoL scores in the overall scale and in the memory/concentration and health distress subscales. These associations remained significant after adjusting for indicators of liver disease severity, including Model for End-Stage Liver Disease-Sodium score and decompensated cirrhosis status. Conclusions: Among patients with cirrhosis, problematic drinking was associated with worse LDQoL, especially in the domains of memory/concentration and health distress. Assessment and awareness of cognitive deficits and negative emotionality within the context of cirrhosis and problematic drinking may help clinicians provide better integrated care for this population. Export